Advertisement
Screener

CARDLYTICS, INC. (CDLX) Proceeds from Sale and Maturity of Marketable Securities

CARDLYTICS, INC. Proceeds from Sale and Maturity of Marketable Securities

CARDLYTICS, INC. (CDLX) reported Proceeds from Sale and Maturity of Marketable Securities of $23.03 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Investing Activities

us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2026-08-05

  • 2026-06-30: Proceeds from Sale and Maturity of Marketable Securities 6 month $23.03M.
  • 2025-06-30: Proceeds from Sale and Maturity of Marketable Securities 6 month $0.00.
Period endProceeds from Sale and Maturity of Marketable Securities 6 month
2026-06-30$23.03M
10-Q · filed 2026-08-05
2025-06-30$0.00
10-Q · filed 2026-08-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM)United States$0.016B-4.22
Global Interactive Technologies, Inc. (GITS)$0.008B
TaoWeave, Inc. (TWAV)United States$0.006B
ZW Data Action Technologies Inc. (CNET)$0.005B-5.46
AIRWA INC. (YYAI)United States$0.004B-101.45
Teads Holding Co. (TEAD)United States$0.045B-0.14
Professional Diversity Network, Inc. (IPDN)United States$0.060B
PodcastOne, Inc. (PODC)United States$0.068B-42.98
Eva Live Inc (GOAI)United States$0.083B
Health Catalyst, Inc. (HCAT)United States$0.132B-0.56